BioNTech SE
Compositions and Methods for Diagnosis and Treatment of Cancer

Last updated:

Abstract:

The present invention relates to the diagnosis and treatment of diseases expressing Fibronectin Extra Domain B (EDB) such as diseases characterized by tissue remodeling and/or angiogenesis, in particular cancerous diseases, such as head and neck, brain, colorectal, lung, prostate and breast cancer. More particularly, the invention concerns peptides targeting Fibronectin Extra Domain B.

Status:
Application
Type:

Utility

Filling date:

6 Jun 2019

Issue date:

12 Aug 2021